Can a single infusion save bones after spinal injury?
NCT ID NCT02325414
Summary
This study tested whether a medication called zoledronic acid could prevent the severe bone loss that often happens after a spinal cord injury. For two years, researchers compared the drug to a placebo in 60 adults who had a recent injury and could not walk independently. The goal was to see if the treatment could help maintain bone density and strength, potentially reducing the risk of fractures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern University Feinberg School of Medicine
Chicago, Illinois, 60611, United States
-
Rehabilitation Institute of Chicago
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.